🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/09/2015 | 139,95 | 145,07 | 131,00 | 131,24 | -4,18% | 10,05% | 1.176.100 |
| 29/09/2015 | 135,11 | 143,42 | 133,58 | 136,97 | +2,10% | 7,28% | 902.600 |
| 28/09/2015 | 135,32 | 137,82 | 129,48 | 134,15 | -2,36% | 6,16% | 956.400 |
| 25/09/2015 | 142,45 | 144,42 | 132,57 | 137,39 | -2,70% | 8,32% | 698.000 |
| 24/09/2015 | 140,92 | 141,56 | 137,65 | 141,20 | -0,55% | 2,77% | 437.000 |
| 23/09/2015 | 145,35 | 145,37 | 140,31 | 141,98 | -1,96% | 3,48% | 684.200 |
| 22/09/2015 | 145,94 | 150,41 | 141,20 | 144,82 | -2,35% | 6,31% | 617.100 |
| 21/09/2015 | 152,45 | 155,14 | 145,22 | 148,31 | -1,59% | 6,51% | 545.000 |
| 18/09/2015 | 151,97 | 154,14 | 150,23 | 150,71 | -2,35% | 2,57% | 656.300 |
| 17/09/2015 | 152,54 | 155,74 | 150,67 | 154,34 | +1,39% | 3,32% | 408.600 |
| 16/09/2015 | 154,66 | 155,78 | 150,22 | 152,22 | -1,74% | 3,59% | 349.700 |
| 15/09/2015 | 154,74 | 155,09 | 152,35 | 154,91 | +0,85% | 1,77% | 423.300 |
| 14/09/2015 | 154,29 | 155,06 | 151,50 | 153,61 | -0,97% | 2,31% | 241.600 |
| 11/09/2015 | 151,52 | 156,26 | 151,52 | 155,11 | +1,54% | 3,13% | 367.700 |
| 10/09/2015 | 151,20 | 155,44 | 151,20 | 152,76 | +0,65% | 2,80% | 317.900 |
| 09/09/2015 | 156,02 | 156,38 | 151,25 | 151,77 | -1,52% | 3,29% | 310.000 |
| 08/09/2015 | 152,17 | 154,47 | 149,51 | 154,12 | +3,29% | 3,26% | 386.500 |
| 04/09/2015 | 148,09 | 151,93 | 147,26 | 149,21 | -0,50% | 3,15% | 267.200 |
| 03/09/2015 | 154,77 | 159,99 | 149,73 | 149,96 | -2,47% | 6,63% | 425.100 |
| 02/09/2015 | 147,06 | 153,97 | 145,57 | 153,75 | +6,32% | 5,71% | 579.300 |
| 01/09/2015 | 148,43 | 153,45 | 144,09 | 144,61 | -3,99% | 6,31% | 1.141.200 |
| 31/08/2015 | 160,00 | 161,99 | 150,21 | 150,62 | -6,14% | 7,36% | 875.700 |
| 28/08/2015 | 159,40 | 161,20 | 157,42 | 160,48 | +0,15% | 2,37% | 391.800 |
| 27/08/2015 | 162,22 | 163,62 | 156,29 | 160,24 | +0,48% | 4,52% | 420.800 |
| 26/08/2015 | 156,82 | 159,72 | 151,39 | 159,47 | +4,45% | 5,31% | 584.100 |
| 25/08/2015 | 155,26 | 156,58 | 151,41 | 152,68 | +1,49% | 3,33% | 717.700 |
| 24/08/2015 | 143,64 | 157,47 | 141,06 | 150,44 | -3,34% | 11,42% | 1.024.000 |
| 21/08/2015 | 160,57 | 163,51 | 155,36 | 155,64 | -4,32% | 5,08% | 555.600 |
| 20/08/2015 | 168,27 | 170,44 | 162,46 | 162,66 | -2,99% | 4,74% | 476.800 |
| 19/08/2015 | 166,63 | 168,90 | 164,65 | 167,68 | +0,06% | 2,55% | 339.000 |